The SmgGDS splice variant SmgGDS-558 is a key promoter of tumor growth and rhoa signaling in breast cancer

Keyphrases

• Breast Cancer 100%
• Breast Cancer Cells 11%
• Breast Tumor 11%
• Cancer Malignancy 11%
• Clinical Outcomes 5%
• Different Characteristics 5%
• Functional Role 5%
• Growth Activity 5%
• Growth Signaling 100%
• Guanine nucleotide Exchange Factor 5%
• In Vivo Tumor Growth 5%
• Kaplan-Meier Survival Curves 5%
• Knockdown 5%
• NF-κB Transcription Factor 5%
• Normal Breast Tissue 5%
• Novel Therapeutic Targets 5%
• Nuclear factor-κB 11%
• Poor Survival 5%
• Protein Expression 5%
• Rho Activation 5%
• RhoA 23%
• RhoA Activity 5%
• RhoA Signaling 100%
• RhoC 11%
• Small GTPase 11%
• SmgGDS 100%
• Splice Variant 100%
• Transcriptional Activity 5%
• Tumor 5%
• Tumor Growth 100%

Immunology and Microbiology

• Breast Tissue 50%
• Cancer Cell 100%
• Guanine Nucleotide Exchange Factor 50%
• Promoter Region 100%
• Protein Expression 50%
• Survival Rate 50%
• Transcription Factors 50%

Medicine and Dentistry

• Breast Cancer 100%
• Breast Tissue 11%
• Breast Tumor 22%
• Cancer 22%
• Cancer Cell 22%
• Guanine Nucleotide Exchange Factor 11%
• In Vitro 11%
• Kaplan Meier Method 11%
• Neoplasm 11%
• Promoter Region 100%
• Protein Expression 11%
• Transcription Factors 11%
• Tumor Progression 100%